🐜
|
RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
21 auth.
B. McCormick,
K. Winter,
C. Hudis,
H. Kuerer,
E. Rakovitch,
Barbara L. Smith,
N. Sneige,
J. Moughan,
A. Shah,
I. Germain,
...
A. Hartford,
A. Rashtian,
E. Walker,
A. Yuen,
E. Strom,
Jeannette L Wilcox,
L. Vallow,
W. Small,
A. Pu,
K. Kerlin,
J. White
|
8 |
2015 |
8 🐜
|
🦁
|
Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy.
A. Rashtian,
S. Iganej,
In-Lu Amy Liu,
S. Natarajan
|
6 |
2008 |
6 🦁
|
🐜
|
Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast
10 auth.
Ronald J. Rivera,
A. Banks,
America Casillas-Lopez,
A. Rashtian,
B. Lewinsky,
P. Sheth,
...
Linda Hovannesian-Larsen,
David Brousseau,
G. Iyengar,
D. Holmes
|
4 |
2016 |
4 🐜
|
🐜
|
Mammographic Findings after Intraoperative Radiotherapy of the Breast
7 auth.
Ronald J. Rivera,
Virginia Smith-Bronstein,
S. Villegas-Mendez,
J. Rayhanabad,
P. Sheth,
A. Rashtian,
...
D. Holmes
|
4 |
2012 |
4 🐜
|
🐬
|
Initial size and dynamics of viral fusion pores are a function of the fusion protein mediating membrane fusion
I. Plonsky,
D. Kingsley,
A. Rashtian,
P. Blank,
J. Zimmerberg
|
3 |
2008 |
3 🐬
|
🐬
|
The use and misuse of positron emission tomography in lung cancer evaluation.
Ching-Fei Chang,
A. Rashtian,
M. Gould
|
3 |
2011 |
3 🐬
|
🐢
|
Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma
Stephen V. Liu,
Naveed Wagle,
G. Zada,
Bonnie Sun,
J. Go,
A. Rashtian
|
3 |
2013 |
3 🐢
|
🐜
|
Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial
17 auth.
M. Seider,
S. Pugh,
C. Langer,
G. Wyatt,
W. Demas,
A. Rashtian,
C. Clausen,
J. Derdel,
S. Cleary,
C. Peters,
...
A. Ramalingam,
J. E. Clarkson,
M. Tomblyn,
R. Rabinovitch,
L. Kachnic,
L. Berk,
For the Mucositis Study Group of the Multinational Ass Oncology
|
3 |
2018 |
3 🐜
|